Financials
- Market Capitalization 956.84 M
- Employee 108
- Founded 2017
- CEO N/A
- Website www.januxrx.com
- Headquarter Delaware, United States
- FIGI BBG00ZHSKH11
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-7.55
Rapporto prezzo/fatturato
62.95
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2486 | ANRO Alto Neuroscience, Inc. Common Stock | 27.04 USD | -2.87% | +0.67% | +24.72% | +944.02% | 948.94 M USD | ||
| 2493 | AVTX Avalo Therapeutics, Inc. - Common Stock | 18.46 USD | +0.22% | -6.91% | +26.53% | +280.62% | 970.36 M USD | ||
| 2512 | SLDB Solid Biosciences Inc. - Common Stock | 9.46 USD | -1.77% | -15.99% | +29.59% | +65.96% | 931.33 M USD | ||
| 2518 | DBVT DBV Technologies S.A. - American Depositary Shares | 15.50 USD | -2.64% | -9.30% | -15.35% | +60.12% | 917.73 M USD |